drugset / Trial / NCT03400423

The Acute Effects of Caffeine on Exercise and Cognition

NCT03400423

Phase 4 Completed 64 enrolled Western University, Canada
RandomizedCrossoverOpen-labelBasic science

Summary

The effects of moderate intensity aerobic exercise and caffeine ingestion on cognition (more specifically working memory) in non-caffeine drinker and caffeine drinkers will be examined. The non-caffeine drinkers will be recruited for two visits, whereas, the caffeine drinkers will be recruited for three visits. The study involves a baseline assessment of cognition and examines the effects of exercise and caffeine. Finally the caffeine group will consist of a baseline and intervention assessment when deprived of caffeine (overnight abstinence). The exercise intervention is to complete 20-minutes of moderate intensity exercise (brisk walk) while the caffeine condition is to consume 1.2 mg/kg of caffeine. Immediately following both intervention the n-back assessment will be conducted.

Timeline

Start
2018-02-01
Primary completion
2019-06-01
Completion
2019-08-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Caffeine Small molecule 1.2 mg/kg Oral

Indications

No indication recorded.